{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(1)"],"submitter":["Rajamaki A"],"funding":["Northern-Savonia Cancer Society","Blood Disease Research Foundation","Finnish Blood Disease Research Foundation"],"pubmed_abstract":["<h4>Aim</h4>The purpose of the study was to evaluate the clinical impact of fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) followed by a new biopsy from the site with maximum standardized uptake value (SUVmax) in case of high maximal SUV values, in detecting clinically unsuspected histologic transformations (HT) of follicular lymphoma (FL).<h4>Methods</h4>This retrospective study included all the patients who had undergone FDG-PET/CT during primary diagnosis or relapse of FL between 2010 and 2020 at Oulu University Hospital.<h4>Results</h4>The diagnosis changed from an indolent disease to a transformed lymphoma in >10% (7/63) of the patients who underwent diagnostic FDG-PET/CT. The HT risk associated with high SUVmax (>10) was 24% (7 of 29 performed biopsi"],"journal":["Cancer medicine"],"pagination":["407-411"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9844644"],"repository":["biostudies-literature"],"pubmed_title":["FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma."],"pmcid":["PMC9844644"],"pubmed_authors":["Kuitunen H","Kuittinen O","Kokkonen SM","Sorigue M","Sunela K","Rajamaki A"],"additional_accession":[]},"is_claimable":false,"name":"FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma.","description":"<h4>Aim</h4>The purpose of the study was to evaluate the clinical impact of fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) followed by a new biopsy from the site with maximum standardized uptake value (SUVmax) in case of high maximal SUV values, in detecting clinically unsuspected histologic transformations (HT) of follicular lymphoma (FL).<h4>Methods</h4>This retrospective study included all the patients who had undergone FDG-PET/CT during primary diagnosis or relapse of FL between 2010 and 2020 at Oulu University Hospital.<h4>Results</h4>The diagnosis changed from an indolent disease to a transformed lymphoma in >10% (7/63) of the patients who underwent diagnostic FDG-PET/CT. The HT risk associated with high SUVmax (>10) was 24% (7 of 29 performed biopsi","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-18T18:19:09.029Z","creation":"2025-04-07T05:56:22.523Z"},"accession":"S-EPMC9844644","cross_references":{"pubmed":["35661431"],"doi":["10.1002/cam4.4924"]}}